Nominations for the 2023 site-based research awards are now CLOSED.
Awards will be presented at the HFSA 2023 Annual Scientific Meeting.
Dear Colleagues,
Thank you for your interest in nominations for the HFC/HFSA joint SBR awards, recognizing top PI’s, Study Coordinators, and Sites. Nominations for the 2023 awards are now CLOSED.
Our goal is to identify and promote the work of those who are outstanding participants in HF clinical trials. We are particularly interested in recognizing the diverse population of scientists across under-represented minority groups, sex, ethnicity, geographic location, and economic landscapes. The nominations will be reviewed by the joint HFC/HFSA Awards Committee in February 2023. Winners will be notified summer 2023 and will receive a $500 award for the HFSA Scientific Annual Meeting. The awards will be presented at the HFSA Annual Scientific Meeting in the fall of 2023.
To be eligible, nominees should have meaningful involvement in a clinical trial listed on ClinTrials.gov. Nominees’ range of accomplishments can include meritorious achievement in trial design, execution/enrollment, and/or reporting scientific content in a trial in which they were involved; as well as challenges encountered and steps taken to meet the challenge in a trial.
Metrics to consider include number of subjects enrolled, enrollment of under-represented group/diverse populations, diverse study groups, data quality, retention, and citizenship (helping other sites participate, participating in trial activities, committee participation, patient recognition and education, dissemination of results).
The number of awards is not fixed, and will be determined by the quality of the applicant pool.